Dynavax to Report Third Quarter 2019 Financial Results and Host Conference Call on November 6

EMERYVILLE, Calif., Oct. 24, 2019 (GLOBE NEWSWIRE) — Dynavax Technologies Corporation (NASDAQ: DVAX), a biopharmaceutical company focused on commercializing novel vaccines, will report third quarter 2019 financial results on Wednesday, November 6, 2019, after the U.S. financial markets close.